Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Antibiotics in Endoscopic Secondary Prevention of GVB
NCT06437964Completed
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- May 2024
- Primary completion
- Jan 2026
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Randomised, open-label trial of ceftriaxone in Gastroesophageal varices (GEV) (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Postoperative fever at 7 days. Started May 2024; status: completed.
02
Drugs
ceftriaxone
03
Conditions
Gastroesophageal varices (GEV)
Beyond the preview
Go deeper on NCT06437964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06437964.